MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Charles River Laboratories International ROE Ratio 2011-2026 | CRL
Annual ROE Ratio Charles River Laboratories International
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.64 | 13.2 | 16.31 | 15.4 | 17.2 | 15.42 | 17.18 | 11.8 | 18.44 | 20.37 | 18.85 | 16.04 | 16.2 | 20.78 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.78 | 0.64 | 15.56 |
Quarterly ROE Ratio Charles River Laboratories International
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.8 | 6.04 | 7.0 | 6.36 | 9.0 | 9.8 | 10.26 | 8.94 | 12.6 | 13.62 | 14.77 | 11.34 | 15.6 | 16.18 | 15.88 | 10.88 | 17.66 | 18.27 | 17.64 | 17.23 | 15.37 | 14.96 | 14.45 | 15.42 | 15.03 | 15.16 | 16.56 | 17.18 | 9.8 | 10.24 | 11.32 | 11.8 | 20.0 | 19.49 | 18.53 | 18.5 | 17.51 | 18.09 | 20.5 | 20.37 | 20.06 | 19.77 | 18.48 | 19.0 | 17.93 | 17.99 | 16.99 | 16.19 | 16.91 | 15.73 | 16.5 | 13.21 | 16.8 | 16.7 | 17.76 | 15.71 | 3.59 | 6.15 | 5.96 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20.5 | 3.59 | 14.52 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 3.03 | -2.26 % | $ 98.3 K |  USA |
 |
Trinity Biotech plc
TRIB
|
287.88 | $ 0.83 | -5.96 % | $ 61.9 M |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 23.35 | -2.91 % | $ 99.4 M | Israel |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 34.5 | 2.16 % | $ 371 M |  China |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.29 | -12.26 % | $ 1.64 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 39.74 | 1.48 % | $ 1.1 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 219.29 | -0.08 % | $ 160 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 102.41 | 0.1 % | $ 19 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 26.19 | -0.19 % | $ 792 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
312.48 | $ 113.17 | 2.43 % | $ 13.9 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
26.18 | $ 73.31 | -0.93 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 20.55 | -1.23 % | $ 1.1 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 109.48 | -2.35 % | $ 4.32 B | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 10.2 | -0.97 % | $ 289 M | Israel |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 66.91 | 0.34 % | $ 4.63 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 144.81 | -3.26 % | $ 23 B | USA |
 |
NeoGenomics
NEO
|
-8.72 | $ 11.99 | -3.35 % | $ 1.52 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
22.63 | $ 230.33 | -2.19 % | $ 41.8 B | USA |
 |
Personalis
PSNL
|
-40.05 | $ 9.33 | -6.42 % | $ 553 M | USA |
 |
Medpace Holdings
MEDP
|
48.98 | $ 582.66 | -1.76 % | $ 18 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 186.45 | 2.27 % | $ 20.7 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 10.11 | 4.66 % | $ 1.31 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
-40.56 | $ 24.07 | -0.78 % | $ 31.2 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 271.34 | 0.56 % | $ 22.8 B | USA |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 370.47 | -1.61 % | $ 29.1 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 181.44 | -2.39 % | $ 15 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 672.84 | -0.57 % | $ 55.5 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 28.66 | -2.02 % | $ 20 B | Niderland |
 |
Agilent Technologies
A
|
22.45 | $ 133.33 | 0.07 % | $ 40.5 B | USA |